Global Paclitaxel-eluting Stent Market Research Report 2019
1 Study Coverage
- 1.1 Paclitaxel-eluting Stent Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Type
- 1.4.2 Metal Stent
- 1.4.3 Polymer Stent
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Application
- 1.5.2 Coronary Heart Disease
- 1.5.3 Clinical
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Paclitaxel-eluting Stent Market Size, Estimates and Forecasts
- 2.1.1 Global Paclitaxel-eluting Stent Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Paclitaxel-eluting Stent Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Paclitaxel-eluting Stent Production Estimates and Forecasts 2015-2026
- 2.2 Global Paclitaxel-eluting Stent, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Paclitaxel-eluting Stent Manufacturers Geographical Distribution
- 2.4 Key Trends for Paclitaxel-eluting Stent Markets & Products
- 2.5 Primary Interviews with Key Paclitaxel-eluting Stent Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity
- 3.1.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Paclitaxel-eluting Stent Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Production
- 3.2 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue
- 3.2.1 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel-eluting Stent Revenue in 2019
- 3.3 Global Paclitaxel-eluting Stent Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Paclitaxel-eluting Stent Production by Regions
- 4.1 Global Paclitaxel-eluting Stent Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Paclitaxel-eluting Stent Regions by Production (2015-2020)
- 4.1.2 Global Top Paclitaxel-eluting Stent Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Paclitaxel-eluting Stent Production (2015-2020)
- 4.2.2 North America Paclitaxel-eluting Stent Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Paclitaxel-eluting Stent Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Paclitaxel-eluting Stent Production (2015-2020)
- 4.3.2 Europe Paclitaxel-eluting Stent Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Paclitaxel-eluting Stent Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Paclitaxel-eluting Stent Production (2015-2020)
- 4.4.2 China Paclitaxel-eluting Stent Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Paclitaxel-eluting Stent Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Paclitaxel-eluting Stent Production (2015-2020)
- 4.5.2 Japan Paclitaxel-eluting Stent Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Paclitaxel-eluting Stent Import & Export (2015-2020)
5 Paclitaxel-eluting Stent Consumption by Region
- 5.1 Global Top Paclitaxel-eluting Stent Regions by Consumption
- 5.1.1 Global Top Paclitaxel-eluting Stent Regions by Consumption (2015-2020)
- 5.1.2 Global Top Paclitaxel-eluting Stent Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Paclitaxel-eluting Stent Consumption by Application
- 5.2.2 North America Paclitaxel-eluting Stent Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Paclitaxel-eluting Stent Consumption by Application
- 5.3.2 Europe Paclitaxel-eluting Stent Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Paclitaxel-eluting Stent Consumption by Application
- 5.4.2 Asia Pacific Paclitaxel-eluting Stent Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Paclitaxel-eluting Stent Consumption by Application
- 5.5.2 Central & South America Paclitaxel-eluting Stent Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Paclitaxel-eluting Stent Consumption by Application
- 5.6.2 Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Paclitaxel-eluting Stent Market Size by Type (2015-2020)
- 6.1.1 Global Paclitaxel-eluting Stent Production by Type (2015-2020)
- 6.1.2 Global Paclitaxel-eluting Stent Revenue by Type (2015-2020)
- 6.1.3 Paclitaxel-eluting Stent Price by Type (2015-2020)
- 6.2 Global Paclitaxel-eluting Stent Market Forecast by Type (2021-2026)
- 6.2.1 Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026)
- 6.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Paclitaxel-eluting Stent Price Forecast by Type (2021-2026)
- 6.3 Global Paclitaxel-eluting Stent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Paclitaxel-eluting Stent Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Paclitaxel-eluting Stent Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 B.Braun Melsengen AG
- 8.1.1 B.Braun Melsengen AG Corporation Information
- 8.1.2 B.Braun Melsengen AG Overview
- 8.1.3 B.Braun Melsengen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 B.Braun Melsengen AG Product Description
- 8.1.5 B.Braun Melsengen AG Related Developments
- 8.2 Biosensors
- 8.2.1 Biosensors Corporation Information
- 8.2.2 Biosensors Overview
- 8.2.3 Biosensors Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Biosensors Product Description
- 8.2.5 Biosensors Related Developments
- 8.3 Biotronik
- 8.3.1 Biotronik Corporation Information
- 8.3.2 Biotronik Overview
- 8.3.3 Biotronik Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Biotronik Product Description
- 8.3.5 Biotronik Related Developments
- 8.4 Blue Medical
- 8.4.1 Blue Medical Corporation Information
- 8.4.2 Blue Medical Overview
- 8.4.3 Blue Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Blue Medical Product Description
- 8.4.5 Blue Medical Related Developments
- 8.5 Boston Scientific
- 8.5.1 Boston Scientific Corporation Information
- 8.5.2 Boston Scientific Overview
- 8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Boston Scientific Product Description
- 8.5.5 Boston Scientific Related Developments
- 8.6 DISA Vascular
- 8.6.1 DISA Vascular Corporation Information
- 8.6.2 DISA Vascular Overview
- 8.6.3 DISA Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 DISA Vascular Product Description
- 8.6.5 DISA Vascular Related Developments
- 8.7 Essen
- 8.7.1 Essen Corporation Information
- 8.7.2 Essen Overview
- 8.7.3 Essen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Essen Product Description
- 8.7.5 Essen Related Developments
- 8.8 Medtronic Vascular
- 8.8.1 Medtronic Vascular Corporation Information
- 8.8.2 Medtronic Vascular Overview
- 8.8.3 Medtronic Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 Medtronic Vascular Product Description
- 8.8.5 Medtronic Vascular Related Developments
- 8.9 MicroPort Medical
- 8.9.1 MicroPort Medical Corporation Information
- 8.9.2 MicroPort Medical Overview
- 8.9.3 MicroPort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 MicroPort Medical Product Description
- 8.9.5 MicroPort Medical Related Developments
- 8.10 Terumo Medical
- 8.10.1 Terumo Medical Corporation Information
- 8.10.2 Terumo Medical Overview
- 8.10.3 Terumo Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Terumo Medical Product Description
- 8.10.5 Terumo Medical Related Developments
- 8.11 Orbusneich
- 8.11.1 Orbusneich Corporation Information
- 8.11.2 Orbusneich Overview
- 8.11.3 Orbusneich Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 Orbusneich Product Description
- 8.11.5 Orbusneich Related Developments
9 Paclitaxel-eluting Stent Production Forecast by Regions
- 9.1 Global Top Paclitaxel-eluting Stent Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Paclitaxel-eluting Stent Regions Forecast by Production (2021-2026)
- 9.3 Key Paclitaxel-eluting Stent Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Paclitaxel-eluting Stent Consumption Forecast by Region
- 10.1 Global Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
- 10.2 North America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
- 10.3 Europe Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Paclitaxel-eluting Stent Sales Channels
- 11.2.2 Paclitaxel-eluting Stent Distributors
- 11.3 Paclitaxel-eluting Stent Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Paclitaxel-eluting Stent Industry
- 12.2 Market Trends
- 12.3 Market Opportunities and Drivers
- 12.4 Market Challenges
- 12.5 Paclitaxel-eluting Stent Market Risks/Restraints
- 12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Paclitaxel-eluting Stent Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Paclitaxel-eluting Stent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel-eluting Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Paclitaxel-eluting Stent market is segmented into
Metal Stent
Polymer Stent
Others
Segment by Application, the Paclitaxel-eluting Stent market is segmented into
Coronary Heart Disease
Clinical
Others
Regional and Country-level Analysis
The Paclitaxel-eluting Stent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Paclitaxel-eluting Stent market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Paclitaxel-eluting Stent Market Share Analysis
Paclitaxel-eluting Stent market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Paclitaxel-eluting Stent by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Paclitaxel-eluting Stent business, the date to enter into the Paclitaxel-eluting Stent market, Paclitaxel-eluting Stent product introduction, recent developments, etc.
The major vendors covered:
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
Terumo Medical
Orbusneich